Susana García-Cerro

Reducing GABA _A α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome

Carmen Martínez‐Cué, Paula Martínez, Noemı́ Rueda et al. · Journal of Neuroscience · 2013 · 154 citations · Full text

Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome

Susana García-Cerro, Paula Martínez, Verónica Vidal et al. · PLoS ONE · 2014 · 106 citations · Full text

Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes

Susana García-Cerro, Noemı́ Rueda, Verónica Vidal et al. · Neurobiology of Disease · 2017 · 94 citations · Full text

Down Syndrome, Neurodegenerative Diseases, Alzheimer's Disease +13

Long‐term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle‐aged <scp>T</scp>s65<scp>D</scp>n mice, a model of <scp>D</scp>own syndrome

Andrea Corrales, Paula Martínez, Susana García-Cerro et al. · Journal of Pineal Research · 2012 · 66 citations

Cholinergic Degeneration, Neurochemical Biomarkers, Melatonin Administration +19

Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder

Natàlia Rodríguez, Ástrid Morer, Europa Azucena González‐Navarro et al. · Journal of Neuroinflammation · 2017 · 63 citations · Full text